GLENMARK LIFE SCIENCIES LTD

GLENMARK LIFE SCIENCES LTD is a manufacturer.

Here is an introduction to the company:

GLENMARK LIFE SCIENCES LTD is a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs) for a wide range of chronic and acute therapeutic areas. The company is headquartered in India and operates as a subsidiary of Glenmark Pharmaceuticals Limited, focusing specifically on the API business.

The core business of Glenmark Life Sciences revolves around the research, development, and production of high-quality APIs, which are the key ingredients in pharmaceutical drugs. They supply these APIs to both Glenmark Pharmaceuticals and other pharmaceutical companies globally. Their product portfolio includes APIs for various therapeutic categories such as cardiovascular disease, central nervous system disorders, pain management, anti-infectives, and diabetes.

Glenmark Life Sciences emphasizes a strong commitment to research and development, aiming to develop complex and niche APIs. They operate state-of-the-art manufacturing facilities that adhere to international regulatory standards, including those of the US FDA, European Medicines Agency (EMA), and other global health authorities. This ensures the quality, safety, and efficacy of their products.

The company's strategic focus is on backward integration for its parent company's products and expanding its customer base with a diversified portfolio of non-captive APIs. They are recognized for their robust R&D capabilities, efficient manufacturing processes, and a strong track record of regulatory compliance, positioning them as a reliable partner in the global pharmaceutical supply chain.

Products manufactured or sold by Glenmark Life Sciences Ltd include:

Active Pharmaceutical Ingredients (APIs):

Telmisartan

Rosuvastatin

Perindopril

Atorvastatin

Olmesartan

Sacubitril

Valsartan

Adapalene

Apremilast

Cabergoline

Clindamycin Phosphate

Diltiazem HCl

Ezetimibe

Fingolimod

Fluticasone Propionate

Ivabradine HCl

Linagliptin

Lurasidone HCl

Mirabegron

Rivaroxaban

Roflumilast

Sitagliptin

Teneligliptin

Tofacitinib

Vildagliptin